Development, Formulation And Evaluation Of Antihypertensive Transdermal Niosomal Gel

Authors

  • Vaibhav L. Narwade
  • Kajol Sonawane
  • Vijaykumar Kale
  • Mahesh Thakare
  • Supriya Mudgulkar

Keywords:

Captopril, Carbopol 934 gel, Niosomal gel, TDDS, Antihypertensive drugs, Stability etc

Abstract

The present study focuses on the development and evaluation of a transdermal niosomal gel formulation of an antihypertensive drug to overcome the limitations associated with oral administration. Niosomes, composed of non-ionic surfactants and cholesterol, were prepared using the modified ether injection method and optimized based on particle shape and entrapment efficiency. The optimized batch (N1) demonstrated spherical vesicles with high drug entrapment and content. Further, the niosomal suspension was incorporated into Carbopol 934 gel to develop transdermal gel formulations (N5–N8) with varying drug concentrations. These formulations were evaluated for physical characteristics including pH, viscosity, consistency, clarity, drug content, entrapment efficiency, and in-vitro drug release using Franz diffusion cells. Among all batches, N8 showed superior performance with 93.80% drug content and 81.14% cumulative drug release at 24 hours, along with desirable physicochemical properties. Stability studies over 30 days confirmed the formulation's integrity under different storage conditions. The results suggest that niosomal gel is a promising transdermal delivery system for sustained and effective delivery of antihypertensive drugs, offering improved bioavailability and patient compliance...

Downloads

Download data is not yet available.

References

[1] Transdermal drug delivery system: An overview. Available from: https://www.researchgate.net/publication/270015915_Transdermal_drug_delivery_system_An_overview [accessed Apr 19 2018].

[2] Soni M. Kumar S, Gupta GD. Transdermal drug delivery: A novel approah to skin permeation. J Pharm Res 2009;2:1184-90

[3] Flynn GL.Percutaneous Absorption. 3rd ed. New York: Marcel Dekker;1985

[4] Merkle HP, Transdermal delivery systems. Method Find Exp Clin Pharmacol 1989; 11:135-53.

[5] Rita Muzzalupo Lorena Tavano. Niosomal drug delivery for transdermal targeting: recent advances. Research and Reports in Transdermal Drug Delivery 2015:4 23-33.

[6] Durgaprasad S, Reetesh R, Kumar H and Rajput R. Effect of a topical curcumin preparation (BIOCURCUMAX) on burn wound healing in rats. Journal of Pharmaceutical and Biomedical Sciences 2011; 08(8):1-3.

[7] Patel SM, Rathod DR, Patel KN, Patel BA and Patel PA. Niosomes as an effective drug delivery: A review. International Journal of Pharmaceutical Research Scholars 2012; 1(2):45-53.

[8] Akhilesh D, Bin KB and Kamath JV. Review on span-60 based non-ionic surfactant vesicles (niosomes) as novel drug delivery. International J of Research in Pharmaceutical and Biomedical Sci 2012; 3 (1):7-12.

[9] Kaur H, Dhiman S and Arora S. Niosomes: a novel drug delivery system. Int. J. Pharm. Sci. Rev. Res 2012; 15(1): 22:113-120.

[10] Shakya V and Bansal BK. Niosomes: A novel trend in drug delivery. International J of Research and Development in Pharmacy and Life Sci 2014, 3(4):1036-1041.

[11] Chandu PV, Arunachalam A, Jeganath S, Yamini K, Tharangini K and Chaitanya C: Niosomes: A novel drug delivery system. International J of Novel Trends in Pharmaceutical Sci 2012; 2(1):25-31.

[12] Gopalakrishnan S and Chenthilnathan A. Niosomes – a novel drug delivery device. Research J of Pharmaceutical, Biological and Chemical Sci 2012; 3(3):1090-1098.

[13] Sankhyan A and Pawar P. Recent trends in niosome as vesicular drug delivery system. J of Applied Pharmaceutical Sci. 2012; 02(06):20-32.

[14] Rahimpour Y and Hamishehkar H. Niosomes as Carrier in Dermal Drug Delivery. Recent Advances in Novel Drug Carrier Systems 2012; Chapter 6.

[15] Rasve V, Chakraborty AK, Jain SK, Vengurlekar S. Comparative evaluation of antidiabetic activity of ethanolic leaves extract of Clematis triloba and their SMEDDS formulation in streptozotocin-induced diabetic rats. J Popul Ther Clin Pharmacol. 2022;29(4):959-971. doi:10.53555/jptcp.v29i04.2360.

[16] Arijit Gandhi, Suma Oomen Sen, Abhijit Paul. Current trends in niosome as vesicular drug delivery system. Asian J of Pharmacy and Life Sci 2012; 2:339-352.

[17] SarfarazMd, Vasantakumar D, Hiremath, D and Goudannavar D. Use of pronisome gel in antidepressant therapy: design and evaluation. World J of Pharmaceutical Res 2014; 3(4):642-656.

[18] Allen TM. Liposomal drug formulations: Rationale for development and what we can expect for the future. Drugs 1998; (56):747-756.

[19] Reddy KVR, Vaishnavi STP, Sravani K, Reddy BV. An approach for design and characterization of niosomes for chlorpheniramine maleate. World J of Pharmaceutical Res; 3(4):1074-1081.

[20] Gowri R, Balaji P, Vijayalakshmi P, PreethyMol G and Karthik RP. Niosomes – A Vesicular Drug Delivery System. International J of Current Res 2013; 5(08):2239-2244.

[21] Khan A, Sharma PK, Visht S and Malviya R. Niosomes as colloidal drug delivery system: A review. Journal ofChronotherapy and Drug Delivery 2011; 2(1):15-21.

[22] Tangri P. and Khurana S. Niosomes: formulation and evaluation. International J of Biopharmaceutics 2011; 2(1):47- 53.

[23] Makeshwar KB and Wasankar SR: Niosome: a Novel Drug Delivery System. Asian J. Pharm. Res 2012; 3(1), 16-20.

[24] Tyagi S, Patel CJ ,Parashar T, Soniya. Novel Drug Delivery System (NDDS): Niosomes. J of Biomedical and Pharmaceutical Res 2012; 1(3):14-21.

[25] Gurjar P, Naik N and Chouksey S: Niosome: A Promising Pharmaceutical Drug Delivery. Int.J.Pharm. Anal 2014; 2(5): 425-431.

[26] Rasve VR, Chakraborty A. A comprehensive review on self-micro emulsifying drug delivery systems (SMEDDS). Int J Pharm Pharm Res. 2022;26(1):206-224.

[27] Chavda Y, Bhimani B, Patel U, Patel G and Daslaniya D: Niosome and Proniosome-Vesicular Structured Dosage Form for Targeted Drug Delivery System. Journal of Advanced Pharmaceutical Research 2011; 2(4):175-184.

[28] Lohumi A, Rawat S, Sarkar S, Sipai AB, Yadav MV. Review article a novel drug delivery system: niosomes review. J of Drug Delivery & Therapeutics 2012; 2(5):129-135.

Downloads

Published

2025-11-12

How to Cite

1.
L. Narwade V, Sonawane K, Kale V, Thakare M, Mudgulkar S. Development, Formulation And Evaluation Of Antihypertensive Transdermal Niosomal Gel. J Neonatal Surg [Internet]. 2025 Nov. 12 [cited 2026 Sep. 5];14(32S):11011-8. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10358

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.